Hepion Pharmaceuticals, Inc. (HEPA) stock
HEPAOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as CTRVP
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q/A on Nov 17, 2026Score 1/30
$0.10−0.00 (-1.45%)
Close on Oct 19, 2026Market cap $7.26MP/E –Yield –
Hepion Pharmaceuticals ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Hepion Pharmaceuticals's ebitda for the twelve months ending Dec 31, 2024 was -$19.32M. For fiscal 2024 it was -$19.32M. The highest annual figure on record is -$1.67M in fiscal 2014.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$19.32M | – |
| FY2023 | Dec 31, 2023 | -$48.38M | – |
| FY2022 | Dec 31, 2022 | -$45.41M | – |
| FY2021 | Dec 31, 2021 | -$30.32M | – |
| FY2020 | Dec 31, 2020 | -$20.11M | – |
| FY2019 | Dec 31, 2019 | -$7.74M | – |
| FY2017 | Jun 30, 2017 | -$21.00M | – |
| FY2016 | Jun 30, 2016 | -$20.78M | – |
| FY2015 | Jun 30, 2015 | -$13.94M | – |
| FY2014 | Jun 30, 2014 | -$1.67M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | -$1.20M | – |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | -$4.46M | – |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -$8.50M | – |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -$5.15M | – |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -$10.40M | – |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | -$10.65M | – |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -$14.15M | – |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -$13.19M | – |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | -$9.75M | – |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | -$8.45M | – |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | -$19.98M | – |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | -$7.23M | – |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | -$8.98M | – |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | -$8.49M | – |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | -$6.83M | – |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | -$6.01M | – |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | -$4.94M | – |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | -$6.22M | – |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | -$4.77M | – |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | -$4.18M | – |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | -$2.24M | – |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | -$1.90M | – |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | -$1.69M | – |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | -$1.92M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | -$5.21M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | -$4.90M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | -$6.02M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | -$4.87M | – |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | -$5.79M | – |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | -$4.65M | – |
| Q2 FY2016CQ4 2015 | Dec 31, 2015 | -$5.51M | – |
| Q1 FY2016CQ3 2015 | Sep 30, 2015 | -$4.84M | – |
| Q4 FY2015CQ2 2015 | Jun 30, 2015 | -$5.37M | – |
See a number that looks wrong?